

Ardelyx stock drops premarket despite revenue beat as investors weigh IBSRELA growth outlook and mixed technical signals heading into 2026.
You can purchase shares of Ardelyx (NASDAQ:ARDX) through any online brokerage.
Other companies in Ardelyx’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Ardelyx has a consensus price target of $12.39.
The stock price for Ardelyx (NASDAQ: ARDX) is $3.1031 last updated October 23, 2026 at 7:58 PM EDT.
There are no upcoming dividends for Ardelyx.
Ardelyx does not have any upcoming earnings scheduled.
There is no upcoming split for Ardelyx.
Ardelyx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and...